Berit Müller

Biochemistry, Genetics and Molecular Biology · Life Sciences

30h-index5.7kcitations111works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Metabolomics and Mass Spectrometry Studies(31), Cancer, Lipids, and Metabolism(28), Fatty Acid Research and Health(22), Breast Cancer Treatment Studies(15), Cancer Genomics and Diagnostics(10)

Publications111 total

Data from Ki67 Measured after Neoadjuvant Chemotherapy for Primary Breast Cancer
2023Open Access
Supplementary Figure Legend from Ki67 Measured after Neoadjuvant Chemotherapy for Primary Breast Cancer
2023Open Access
Supplementary Figure from Ki67 Measured after Neoadjuvant Chemotherapy for Primary Breast Cancer
2023Open Access
Supplementary Figure Legend from Ki67 Measured after Neoadjuvant Chemotherapy for Primary Breast Cancer
2023Open Access
Data from Ki67 Measured after Neoadjuvant Chemotherapy for Primary Breast Cancer
2023Open Access
Supplementary Figure from Ki67 Measured after Neoadjuvant Chemotherapy for Primary Breast Cancer
2023Open Access
Supplementary Table 8 from Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
2023Open Access
Supplementary Table 1 from Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
2023Open Access
Supplementary Table 6 from Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
2023Open Access
Supplementary Table 1 from Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
2023Open Access
Supplementary Table 6 from Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
2023Open Access
Supplementary Table 4 from Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
2023Open Access
Supplementary Table 5 from Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
2023Open Access
Supplementary Table 8 from Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
2023Open Access
Supplementary Figures 1-2 from Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
2023Open Access
Supplementary Methods from Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
2023Open Access
Supplementary Table 5 from Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
2023Open Access
Supplementary Table 7 from Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
2023Open Access
Supplementary Table 7 from Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
2023Open Access
Supplementary Table 4 from Novel Theranostic Opportunities Offered by Characterization of Altered Membrane Lipid Metabolism in Breast Cancer Progression
2023Open Access
page 1 of 6Next →

Frequent Co-authors

Carsten Denkert(38), Manfred Dietel(28), Jan Budczies(25), Silvia Darb‐Esfahani(17), Wilko Weichert(16), Aurelia Noske(14), Sibylle Loibl(13), Bruno V. Sinn(13), Gϋnter von Minckwitz(10), Ralf Kronenwett(9), Judith Prinzler(8), Jalid Sehouli(7), Julian L. Griffin(6), Oliver Fiehn(6), Matej Orešič(6), Areeg Faggad(6), Christoph Petry(6), Bernd Gerber(5), Jens‐Uwe Blohmer(5), Scarlet Brockmöller(5)